nonalcoholic%20fatty%20liver%20disease
NONALCOHOLIC FATTY LIVER DISEASE

Nonalcoholic fatty liver disease is having excessive hepatic fat (in the form of triglycerides) accumulation not due to excessive alcohol consumption or other secondary causes.

It is considered as a hepatic manifestation of metabolic syndrome.

Progression of nonalcoholic fatty liver disease is variable.

Drug Information
Essentiale Forte N
phospholipids

Indication: Nutritional support in the management of damaged liver (due to chronic liver disease, liver cirrhosis, fatty l...

Livolin Forte
nicotinamide + phospholipids + vitamin B1 + vitami...

Indication: Health supplement.

Shine Hepavite
calcium pantothenate + cyanocobalamin + nicotinami...

Indication: Adjuvant treatment of chronic liver disease, liver cirrhosis, fatty liver & intoxication by hepatotoxic su...

Shine Hepavite Forte
calcium pantothenate + nicotinamide + pyridoxine h...

Indication: Adjuvant treatment of chronic liver diseases, liver cirrhosis, fatty liver & intoxication by hepatotoxic s...

Simepar
calcium pantothenate + nicotinamide + silymarin + ...

Indication: Toxic & inflammatory liver disorders. Adjuvant in chronic liver disease.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 04 May 2019
Peppermint oil may be effective for relieving dysphagia and chest pain caused by oesophageal motility disorders, according to a new study.
12 Oct 2017
Electromyographic biofeedback (EMG-BF) appears to be an effective behavioural therapy for improving dyssynergic defecation in chronically constipated community-dwelling elderly women, according to a recent study.
20 Mar 2019
Adequate tea drinking (<240 ml/day or 19 cup-years) may help lower the risk of gallstones in both men and women, a recent Taiwan study has shown.
Roshini Claire Anthony, 07 May 2019

The trend in liver disease-related mortality in individuals with HIV has changed, with a reduction in the incidence of viral hepatitis-related deaths and an increase in non-alcoholic fatty liver disease (NAFLD)-related deaths, according to a study presented at the International Liver Congress (ILC 2019).